Clinical Trials : Pheochromocytoma

Completed

Study Name: Diagnosis and Treatment of Pheochromocytoma
Condition: Pheochromocytoma
Date: 1999-11-03

Completed

Study Name: 131MIBG to Treat Malignant Pheochromocytoma
Condition: Pheochromocytoma
Date: 2001-12-11
Interventions:

Drug: [131]I-MIBG
Drug: 6-[18F]Fluorodopam

Recruiting

Study Name: Diagnosis of Pheochromocytoma
Condition: Pheochromocytoma
Date: 2000-03-02

Completed

Study Name: I-123-MIBG for Imaging of Neuroblastoma and Pheochromocytoma
Condition:

Neuroblastoma
Pheochromocytoma

Date: 2007-12-27

Recruiting

Study Name: MIBG for Refractory Neuroblastoma and Pheochromocytoma
Condition:

Relapsed Neuroblastoma
Metastatic Pheochromocytoma

Date: 2013-03-26
Interventions:

Drug: 131 I-Metaiodobenzylguanidine (131I-MIBG)

Recruiting

Study Name: Phenoxybenzamine Versus Doxazosin in PCC Patients
Condition: Pheochromocytoma
Date: 2011-05-19
Interventions:

Drug: Phenoxybenzamine Startin

Terminated

Study Name: Content Validation of Quality of Life and Symptom Questionnaires for Pheochromocytoma and Paraganglioma
Condition:

Pheochromocytoma
Paraganglioma

Date: 2009-05-29

Temporarily not available

Study Name: A Compassionate Use/Expanded Access Protocol Using 131I-MIBG Therapy for Patients With Refractory Neuroblastoma and Metastatic Pheochromocytoma
Condition:

Neuroblastoma
Pheochromocytoma

Date: 2017-01-05
Interventions: Drug: 131-I-meta-iodobenzylguanidine Other Names:

131I-MIBG
Io

Recruiting

Study Name: First International Randomized Study in Malignant Progressive Pheochromocytoma and Paraganglioma
Condition: Malignant Progressive Pheochromocytoma and Paraganglioma (PPGL)
Date: 2011-06-09
Interventions:

Drug: Sunitinib sunitinib 37.5

Completed

Study Name: Study Of Sunitinib In Patients With Recurrent Paraganglioma/Pheochromocytoma
Condition:

Paraganglioma
Pheochromocytoma

Date: 2009-02-12
Interventions: Drug: Sunitinib 50 mg oral dose daily for 4 weeks, 2 week rest period (repeating 6 week cycles)

Search for Clinical Trial Results

Pheochromocytoma - 26 Studies Found

Status	Study
Completed	Study Name: Diagnosis and Treatment of Pheochromocytoma Condition: Pheochromocytoma Date: 1999-11-03
Completed	Study Name: 131MIBG to Treat Malignant Pheochromocytoma Condition: Pheochromocytoma Date: 2001-12-11 Interventions: Drug: [131]I-MIBG Drug: 6-[18F]Fluorodopam
Recruiting	Study Name: Diagnosis of Pheochromocytoma Condition: Pheochromocytoma Date: 2000-03-02
Completed	Study Name: I-123-MIBG for Imaging of Neuroblastoma and Pheochromocytoma Condition: Neuroblastoma Pheochromocytoma Date: 2007-12-27
Recruiting	Study Name: MIBG for Refractory Neuroblastoma and Pheochromocytoma Condition: Relapsed Neuroblastoma Metastatic Pheochromocytoma Date: 2013-03-26 Interventions: Drug: 131 I-Metaiodobenzylguanidine (131I-MIBG)
Recruiting	Study Name: Phenoxybenzamine Versus Doxazosin in PCC Patients Condition: Pheochromocytoma Date: 2011-05-19 Interventions: Drug: Phenoxybenzamine Startin
Terminated	Study Name: Content Validation of Quality of Life and Symptom Questionnaires for Pheochromocytoma and Paraganglioma Condition: Pheochromocytoma Paraganglioma Date: 2009-05-29
Temporarily not available	Study Name: A Compassionate Use/Expanded Access Protocol Using 131I-MIBG Therapy for Patients With Refractory Neuroblastoma and Metastatic Pheochromocytoma Condition: Neuroblastoma Pheochromocytoma Date: 2017-01-05 Interventions: Drug: 131-I-meta-iodobenzylguanidine Other Names: 131I-MIBG Io
Recruiting	Study Name: First International Randomized Study in Malignant Progressive Pheochromocytoma and Paraganglioma Condition: Malignant Progressive Pheochromocytoma and Paraganglioma (PPGL) Date: 2011-06-09 Interventions: Drug: Sunitinib sunitinib 37.5
Completed	Study Name: Study Of Sunitinib In Patients With Recurrent Paraganglioma/Pheochromocytoma Condition: Paraganglioma Pheochromocytoma Date: 2009-02-12 Interventions: Drug: Sunitinib 50 mg oral dose daily for 4 weeks, 2 week rest period (repeating 6 week cycles)